Showing 641 - 660 results of 8,861 for search 'significantly ((((mean decrease) OR (greatest decrease))) OR (((we decrease) OR (nn decrease))))', query time: 0.80s Refine Results
  1. 641
  2. 642
  3. 643
  4. 644
  5. 645

    Clinical characteristics. by Clemens Plattner (21567706)

    Published 2025
    “…Survival curves were estimated using the Kaplan-Meier plot and compared using the Log-rank test.</p><p>Results</p><p>Mean age at T2D diagnosis was significantly lower in the FHD group, while time to insulin initiation was independent from FHD status. …”
  6. 646
  7. 647
  8. 648
  9. 649
  10. 650
  11. 651
  12. 652
  13. 653
  14. 654

    <b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

    Published 2025
    “…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”
  15. 655

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”
  16. 656
  17. 657
  18. 658

    Supplementary Material for: Decreased Lactococcus lactis and propionic acid in feces of patients with Moyamoya disease: Possible implications of immune dysregulation by figshare admin karger (2628495)

    Published 2025
    “…The gut microbiota produces short-chain fatty (SCFA) and organic acids, influencing immune regulation and vascular remodeling. We aimed to characterize the gut microbiota in patients with MMD. …”
  19. 659
  20. 660